We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Secukinumab 300 mg administered with an auto-injector ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD Intevia™ 1 mL two-step disposable autoinjector, a robust platform device combining ...
A quiet shift has been unfolding in beauty conversations. Rather than chasing dramatic transformations, more people are ...
Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end 2024, if successful BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results